Cardlytics, Inc.

NasdaqGM:CDLX Voorraadrapport

Marktkapitalisatie: US$206.8m

Cardlytics Toekomstige groei

Future criteriumcontroles 0/6

De verwachting is dat Cardlytics de winst en omzet met respectievelijk 35.3% en 5.5% per jaar zal laten groeien, terwijl de winst per aandeel naar verwachting zal groeien met 57.9% per jaar.

Belangrijke informatie

35.3%

Groei van de winst

57.9%

Groei van de winst per aandeel

Media winstgroei13.6%
Inkomstengroei5.5%
Toekomstig rendement op eigen vermogenn/a
Dekking van analisten

Good

Laatst bijgewerkt07 Nov 2024

Recente toekomstige groei-updates

Recent updates

After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar

Nov 05
After Leaping 27% Cardlytics, Inc. (NASDAQ:CDLX) Shares Are Not Flying Under The Radar

Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?

Oct 15
Is Cardlytics (NASDAQ:CDLX) Using Too Much Debt?

Cardlytics: Execution Risks Are Elevated, But Reasons For Optimism Remain (Maintain Hold Rating)

Sep 17

Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk

Aug 09
Cardlytics, Inc.'s (NASDAQ:CDLX) 63% Share Price Plunge Could Signal Some Risk

Cardlytics: Has Multiple Potential Growth Levers, But Persistent Risks Remain

Jul 02

Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

May 31
Cardlytics, Inc.'s (NASDAQ:CDLX) Stock Retreats 30% But Revenues Haven't Escaped The Attention Of Investors

The Power Of Cardlytics' Data Partnerships Including Bank of America

Apr 17

Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors

Apr 10
Cardlytics, Inc.'s (NASDAQ:CDLX) 81% Jump Shows Its Popularity With Investors

Cardlytics: Good Prospects But Macro Uncertain

Feb 16

Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk

Jan 18
Cardlytics, Inc.'s (NASDAQ:CDLX) 29% Share Price Plunge Could Signal Some Risk

Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?

Jan 04
Would Cardlytics (NASDAQ:CDLX) Be Better Off With Less Debt?

We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt

Oct 05
We Think Cardlytics (NASDAQ:CDLX) Has A Fair Chunk Of Debt

Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?

Jun 18
Does Cardlytics (NASDAQ:CDLX) Have A Healthy Balance Sheet?

Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Apr 17
Cardlytics, Inc. (NASDAQ:CDLX) Stock Rockets 105% But Many Are Still Ignoring The Company

Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Mar 03
Is Cardlytics, Inc. (NASDAQ:CDLX) Trading At A 38% Discount?

Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Jan 10
Is Cardlytics (NASDAQ:CDLX) A Risky Investment?

Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

Oct 12
Is Cardlytics (NASDAQ:CDLX) Using Debt In A Risky Way?

Cardlytics: 6 Bear Cases To Consider

Oct 10

Winst- en omzetgroeiprognoses

NasdaqGM:CDLX - Toekomstschattingen van analisten en financiële gegevens uit het verleden (USD Millions )
DatumInkomstenInkomstenVrije kasstroomGeldmiddelen uit operationele activiteitenGem. Aantal analisten
12/31/2026323-71N/A71
12/31/2025284-78-1016
12/31/2024265-72-19-126
9/30/2024293-275-27-9N/A
6/30/2024305-153-26-9N/A
3/31/2024312-173-22-8N/A
12/31/2023309-135-130N/A
9/30/2023303-412-28-16N/A
6/30/2023296-382-44-32N/A
3/31/2023295-485-58-44N/A
12/31/2022299-465-67-54N/A
9/30/2022306-99-55-41N/A
6/30/2022298-150-51-37N/A
3/31/2022282-71-58-46N/A
12/31/2021267-129-51-39N/A
9/30/2021244-124-45-32N/A
6/30/2021225-94-40-27N/A
3/31/2021195-67-29-17N/A
12/31/2020187-55-18-8N/A
9/30/2020189-45-20-9N/A
6/30/2020199-38-27N/A
3/31/2020220-24-110N/A
12/31/2019210-17011N/A
9/30/2019189-32-73N/A
6/30/2019167-33-20-9N/A
3/31/2019154-39-29-20N/A
12/31/2018151-53-26-19N/A
9/30/2018142-46-25-20N/A
6/30/2018139-41N/A-29N/A
3/31/2018136-33N/A-16N/A
12/31/2017130-25N/A-22N/A
9/30/2017128-28N/A-19N/A
6/30/2017127-51N/A-16N/A
3/31/2017120-77N/A-26N/A
12/31/2016113-77N/A-32N/A
12/31/201578-42N/A-29N/A

Toekomstige groeivoorspellingen analisten

Verdiensten versus spaarpercentage: De verwachting is dat CDLX de komende 3 jaar verliesgevend zal blijven.

Winst versus markt: De verwachting is dat CDLX de komende 3 jaar verliesgevend zal blijven.

Hoge groeiwinsten: De verwachting is dat CDLX de komende 3 jaar verliesgevend zal blijven.

Omzet versus markt: De omzet van CDLX ( 5.5% per jaar) zal naar verwachting langzamer groeien dan de markt US ( 8.9% per jaar).

Hoge groei-inkomsten: De omzet van CDLX ( 5.5% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.


Groeiprognoses winst per aandeel


Toekomstig rendement op eigen vermogen

Toekomstige ROE: Onvoldoende gegevens om te bepalen of het rendement op eigen vermogen van CDLX naar verwachting over 3 jaar hoog zal zijn


Ontdek groeibedrijven